Davide Bolignano
Basic info is private.
Interests
The epidemiology and pathophysiology of chronic and acute kidney diseases; Renal biomarkers; Cerythropoietin and stem cells in uremia
Latest Publications
- Open Access Original ResearchDecreased Cathepsin-K Mirrors the Severity of Subclinical Atherosclerosis in Kidney Transplant RecipientsDavide Bolignano, Marta Greco, Valentina Arcidiacono, Pierangela Presta, ... Giuseppe CoppolinoRev. Cardiovasc. Med. 2022, 23(9), 311; https://doi.org/10.31083/j.rcm2309311(This article belongs to the Section CardioRenal)36Downloads163Views
- Open Access Original ResearchAltered circulating marinobufagenin levels and recurrent intradialytic hypotensive episodes in chronic hemodialysis patients: a pilot, prospective studyDavide Bolignano, Marta Greco, Pierangela Presta, Giuseppina Crugliano, ... Giuseppe CoppolinoRev. Cardiovasc. Med. 2021, 22(4), 1577–1587; https://doi.org/10.31083/j.rcm2204163(This article belongs to the Special Issue Featured Papers in Cardiovascular Medicine 2021)95Downloads6Citations265Views
- Open Access ReviewRenal nerve ablation for resistant hypertension: facts, fictions and future directionsDavide Bolignano, Giuseppe CoppolinoRev. Cardiovasc. Med. 2019, 20(1), 9–18; https://doi.org/10.31083/j.rcm.2019.01.5180Downloads3Citations194Views
- Open Access ReviewPulmonary hypertension: a neglected risk condition in renal patients?Davide Bolignano, Anna Pisano, Graziella D’ArrigoRev. Cardiovasc. Med. 2018, 19(4), 117–121; https://doi.org/10.31083/j.rcm.2018.04.31881078Downloads4Citations564Views
- Open Access ReviewBaroreflex stimulation for treating resistant hypertension: ready for the prime-time?Davide Bolignano, Giuseppe CoppolinoRev. Cardiovasc. Med. 2018, 19(3), 89–95; https://doi.org/10.31083/j.rcm.2018.03.31851131Downloads2Citations619Views